BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
BioAge Labs has raised $115.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
BioAge Labs's investors include Andreessen Horowitz, RA Capital Management, Khosla Ventures, Pear VC, Caffeinated Capital.
BioAge Labs is headquartered in Richmond, United States.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
BioAge Labs is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioAge Labs — Funding & Investors." VCBacked, January 21, 2026, https://www.vcbacked.co/company/bioage-labs. Accessed July 19, 2026.
VCBacked. (2026). BioAge Labs — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/bioage-labs
{{cite web |title=BioAge Labs — Funding & Investors |url=https://www.vcbacked.co/company/bioage-labs |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated